Lycia Therapeutics

LYCA

全部股東

股東類型

  • 公眾及其他48.11%
  • 創投/私募22.94%
  • 對沖基金13.53%
  • 機構投資者10.55%
  • 其他4.87%

主要股東

主要股東 最新
股東
Versant Venture Management, LLC
12.18%702.53 萬--+702.53 萬26/10/2026
VR Management, LLC
10.76%620.68 萬--+620.68 萬
Redmile Group, LLC
7.22%416.49 萬--+416.49 萬23/10/2026
RTW Investments, LP
6.31%363.94 萬--+363.94 萬23/10/2026
Janus Henderson Group Ltd.
6.03%347.62 萬--+347.62 萬23/10/2026
Blue Owl Credit Private Fund Advisors LLC
3.39%195.56 萬--+195.56 萬23/10/2026
Eli Lilly and Company
1.91%110.46 萬--+110.46 萬22/10/2026
Carolyn BertozziFounder & Chair of Scientific Advisory Board
1.57%90.48 萬--+90.48 萬22/10/2026
Venrock Management, LLC
1.13%65.18 萬--+65.18 萬
Aetna TrombleyCEO, Secretary, President & Director
0.72%41.53 萬--+41.53 萬23/10/2026
Clare OzawaFormer Independent Director
0.36%20.52 萬--+20.52 萬23/10/2026
William RieflinIndependent Chair of the Board
0.16%8.98 萬--+8.98 萬23/10/2026
Steven StabenChief Scientific Officer
0.10%5.54 萬--+5.54 萬23/10/2026
Laurent FischerIndependent Director
0.06%3.33 萬--+3.33 萬23/10/2026
Chin Hyok LeeChief Medical Officer
0.00%0.00--+023/10/2026
Jane Pritchett HendersonIndependent Director
0.00%0.00--+023/10/2026